# Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients

> **NCT06448143** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Prove pharm** · enrollment: 18 (estimated)

## Conditions studied

- Ureter Injury

## Interventions

- **DRUG:** Indigotindisulfonate sodium 0.8% injection

## Key facts

- **NCT ID:** NCT06448143
- **Lead sponsor:** Prove pharm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06448143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06448143, "Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT06448143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*